Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LYEL
NNNN
Add up to 3 more stocks
LYEL
Lyell Immunopharma, Inc.
-5.07%
$8.61-0.46Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$210.98M
52W Range
$8.66 - $45.00
NNNN
Anbio Biotechnology Class A Ordinary Shares
+1.45%
$4.90+0.07Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$215.07M
52W Range
$4.66 - $44.73
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.90 | 7.13 |
| P/S Ratio | 7814.17 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -31952.8% | 87.2% |
| Operating Margin | -566038.9% | 66.7% |
| Net Margin | -920285.2% | 74.1% |
| ROE | -106.3% | 21.2% |
| ROA | -79.9% | 21.2% |
| ROIC | -70.8% | 19.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.36 | 344.31 |
| Quick Ratio | 5.36 | 344.31 |
| Debt/Equity | 0.16 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.